The role of genomics in antimicrobial discovery.
Mills
Scott D
SD
AstraZeneca R&D Boston, Infection Discovery, 35 Gatehouse Drive, Waltham, MA 02451, USA. scott.mills@astrazeneca.com
D000581:Amidohydrolases / Q000009:adverse effects / Q000737:chemistry / Q000235:genetics; D000890:Anti-Infective Agents / Q000494:pharmacology*; D016503:Drug Delivery Systems; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005827:Genetics, Microbial / Q000295:instrumentation / Q000379:methods; D023281:Genomics / Q000295:instrumentation / Q000379:methods; D008718:Methionine-tRNA Ligase / Q000037:antagonists & inhibitors / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis
D000890:Anti-Infective Agents; D004791:Enzyme Inhibitors; D000581:Amidohydrolases; C097307:UDP-3-O-acyl-N-acetylglucosamine deacetylase; C084507:peptide deformylase; D008718:Methionine-tRNA Ligase